187 related articles for article (PubMed ID: 36004470)
1. CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker.
Hu H; Xiang Y; Zhang XY; Deng Y; Wan FJ; Huang Y; Liao XH; Zhang TC
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004470
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A.
Wang Y; Yao J; Zhu Y; Zhao X; Lv J; Sun F
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35506437
[TBL] [Abstract][Full Text] [Related]
3. Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.
Huang X; Huang Y; Lv Z; Wang T; Feng H; Wang H; Du S; Wu S; Shen D; Wang C; Li H; Wang B; Ma X; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642672
[TBL] [Abstract][Full Text] [Related]
4. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Chong Y; Xue L
Crit Rev Eukaryot Gene Expr; 2021; 31(1):29-40. PubMed ID: 33639053
[TBL] [Abstract][Full Text] [Related]
6. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
8. KLF5-mediated CDCA5 expression promotes tumor development and progression of epithelial ovarian carcinoma.
Chen X; Zhou M; Ma S; Wu H; Cai H
Exp Cell Res; 2023 Aug; 429(1):113645. PubMed ID: 37247719
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
10. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
Kariri YA; Joseph C; Alsaleem MA; Elsharawy KA; Alsaeed S; Toss MS; Mongan NP; Green AR; Rakha EA
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428736
[TBL] [Abstract][Full Text] [Related]
12. LINC01515 promotes nasopharyngeal carcinoma progression by serving as a sponge for miR-325 to up-regulate CDCA5.
Liu D; Gong H; Tao Z; Chen S; Kong Y; Xiao B
J Mol Histol; 2021 Jun; 52(3):577-587. PubMed ID: 33770322
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
Huang Z; Zhang S; Du J; Zhang X; Zhang W; Huang Z; Ouyang P
Med Sci Monit; 2020 Aug; 26():e923664. PubMed ID: 32759885
[TBL] [Abstract][Full Text] [Related]
14. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
15. TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5.
Jin X; Wang D; Lei M; Guo Y; Cui Y; Chen F; Sun W; Chen X
J Transl Med; 2022 May; 20(1):191. PubMed ID: 35509067
[TBL] [Abstract][Full Text] [Related]
16. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
Tian Y; Wu J; Chagas C; Du Y; Lyu H; He Y; Qi S; Peng Y; Hu J
BMC Cancer; 2018 Nov; 18(1):1187. PubMed ID: 30497429
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
18. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
Zhang Q; Zhang R; Li Y; Yang X
J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
[TBL] [Abstract][Full Text] [Related]
19. Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non-small cell lung cancer cells via p53-p21 signaling pathway.
Shen W; Tong D; Chen J; Li H; Hu Z; Xu S; He S; Ge Z; Zhang J; Mao Q; Chen H; Xu G
J Clin Lab Anal; 2022 May; 36(5):e24396. PubMed ID: 35373420
[TBL] [Abstract][Full Text] [Related]
20. Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma.
Hou S; Chen X; Li M; Huang X; Liao H; Tian B
Aging (Albany NY); 2020 Jul; 12(14):14542-14555. PubMed ID: 32694239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
